News

Price Target Raised on Biopharma Achieving Positive Atopic Dermatitis Study Results

June 24, 2021 (Investorideas.com Newswire) Aclaris Therapeutics’ new clinical trial data and a recent financing are discussed in an H.C. Wainwright & Co. report.

What's your reaction?

Excited
0
Happy
0
In Love
0
Not Sure
0
Silly
0

You may also like

Leave a reply

Your email address will not be published. Required fields are marked *

More in:News

News

Against Bond Market Odds

October 22, 2021 (Investorideas.com Newswire) Such was the S&P 500 correction, how did you like ...